Clinical Trial Update: Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

View source ↗

Summary

A completed clinical trial update examining metabolite levels in ovarian cancer patients receiving maintenance PARP inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Ovarian Carcinoma | Status: COMPLETED